NO20082439L - Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma - Google Patents

Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma

Info

Publication number
NO20082439L
NO20082439L NO20082439A NO20082439A NO20082439L NO 20082439 L NO20082439 L NO 20082439L NO 20082439 A NO20082439 A NO 20082439A NO 20082439 A NO20082439 A NO 20082439A NO 20082439 L NO20082439 L NO 20082439L
Authority
NO
Norway
Prior art keywords
treatment
tiotropium salts
persistent asthma
moderate persistent
moderate
Prior art date
Application number
NO20082439A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Engel
Stefan Heinrichs
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35695896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20082439(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20082439L publication Critical patent/NO20082439L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20082439A 2006-01-04 2008-05-28 Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma NO20082439L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100055 2006-01-04
PCT/EP2006/070135 WO2007077162A1 (en) 2006-01-04 2006-12-22 Use of tiotropium salts in the treatment of moderate persistent asthma

Publications (1)

Publication Number Publication Date
NO20082439L true NO20082439L (no) 2008-08-04

Family

ID=35695896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082439A NO20082439L (no) 2006-01-04 2008-05-28 Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma

Country Status (30)

Country Link
US (2) US20070155773A1 (de)
EP (1) EP1971332B1 (de)
JP (1) JP2009525950A (de)
KR (1) KR20080083060A (de)
CN (1) CN101355937A (de)
AR (1) AR059126A1 (de)
AT (1) ATE500825T1 (de)
AU (1) AU2006334367B2 (de)
BR (1) BRPI0620886A2 (de)
CA (1) CA2634984C (de)
CY (1) CY1111534T1 (de)
DE (1) DE602006020620D1 (de)
DK (1) DK1971332T3 (de)
EA (1) EA015353B1 (de)
EC (1) ECSP088588A (de)
ES (1) ES2362306T3 (de)
HR (1) HRP20110200T1 (de)
IL (1) IL192602A (de)
ME (1) ME01205B (de)
MY (1) MY146362A (de)
NO (1) NO20082439L (de)
NZ (1) NZ570162A (de)
PL (1) PL1971332T3 (de)
PT (1) PT1971332E (de)
RS (1) RS51703B (de)
SI (1) SI1971332T1 (de)
TW (1) TW200731976A (de)
UA (1) UA95271C2 (de)
WO (1) WO2007077162A1 (de)
ZA (1) ZA200804436B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1915158A1 (de) 2005-08-06 2008-04-30 Boehringer Ingelheim International GmbH Verwendung von tiotropiumsalzen bei der behandlung von schwerem persistierendem asthma
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN110876720A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用
CN110876721A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 一种含有表面活性剂的噻托溴铵喷雾剂

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2425539A (en) * 1942-10-31 1947-08-12 Aro Equipment Corp Coupling
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
WO2002030928A1 (de) * 2000-10-12 2002-04-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
ME00349B (de) * 2003-11-03 2011-05-10 Boehringer Ingelheim Int Neues kristallines anhydrat mit anticholinerger wirksamkeit
JP5165244B2 (ja) * 2003-11-03 2013-03-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング チオトロピウム塩の製法、チオトロピウム塩及びそれを含有する医薬組成物
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
KR20080011289A (ko) * 2005-05-10 2008-02-01 시너젠즈 바이오사이언스 리미티드 폐기능 및 폐질환을 평가하기 위한 성분 및 평가 방법
WO2006123943A1 (en) * 2005-05-20 2006-11-23 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
EP1915158A1 (de) * 2005-08-06 2008-04-30 Boehringer Ingelheim International GmbH Verwendung von tiotropiumsalzen bei der behandlung von schwerem persistierendem asthma
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide

Also Published As

Publication number Publication date
DE602006020620D1 (de) 2011-04-21
AU2006334367A1 (en) 2007-07-12
ME01205B (me) 2013-03-20
BRPI0620886A2 (pt) 2011-11-29
US20070155773A1 (en) 2007-07-05
PL1971332T3 (pl) 2011-08-31
CY1111534T1 (el) 2015-08-05
ECSP088588A (es) 2008-07-30
UA95271C2 (ru) 2011-07-25
JP2009525950A (ja) 2009-07-16
SI1971332T1 (sl) 2011-05-31
ZA200804436B (en) 2008-12-31
IL192602A (en) 2013-06-27
RS51703B (sr) 2011-10-31
ATE500825T1 (de) 2011-03-15
KR20080083060A (ko) 2008-09-12
AU2006334367B2 (en) 2012-11-08
AR059126A1 (es) 2008-03-12
CA2634984C (en) 2014-05-06
TW200731976A (en) 2007-09-01
CN101355937A (zh) 2009-01-28
MY146362A (en) 2012-08-15
EP1971332A1 (de) 2008-09-24
EP1971332B1 (de) 2011-03-09
IL192602A0 (en) 2009-09-22
EA015353B1 (ru) 2011-06-30
HRP20110200T1 (hr) 2011-04-30
ES2362306T3 (es) 2011-07-01
NZ570162A (en) 2011-09-30
EA200801629A1 (ru) 2008-12-30
DK1971332T3 (da) 2011-04-18
PT1971332E (pt) 2011-03-18
WO2007077162A1 (en) 2007-07-12
CA2634984A1 (en) 2007-07-12
US20150224090A1 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
WO2009153665A3 (en) Inhibitors of the shiga toxins trafficking through the retrograde pathway
DK1765349T3 (da) Opioider til behandling af kronisk obstruktiv lungesygdom
MX346186B (es) Inhibidores de proteina cinasas.
MX2010002732A (es) Inhibidores de f1f0-atpasa y metodos relacionados.
EA201400591A1 (ru) Ингалятор
MX341212B (es) Inhibidor de bromodominio de benzodiazepina.
WO2007144327A3 (en) Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
ATE524450T1 (de) 5-phenyl-isoxazol-3-carboxamid-derivate als trpv1-modulatoren
NO20084328L (no) Nye forbindelser
WO2007048801A3 (en) Sexual desire enhancing medicaments comprising benzimidazolone derivatives
EA201201397A1 (ru) Ингалятор, содержащий расслаиваемую блистерную упаковку
UA100777C2 (ru) Вдыхаемые частички, содержащие тиотропий
TN2009000275A1 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
EA201171172A1 (ru) Применение в терапии производных хиназолиндиона
EA201290603A1 (ru) Способ лечения
NO20081480L (no) Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma
NO20082439L (no) Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
EA200900261A1 (ru) Применение эсцина
EA201201395A1 (ru) Кнопочное устройство мундштука ингалятора сухого порошка
SI1940409T1 (sl) Nove zdravilske kombinacije za zdravljenje bolezni dihalnih poti
AU2012308243A8 (en) Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
NZ597359A (en) Emergency interventions of active charcoal with dabigatran etexilate overdosing

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application